| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/09/2004 | WO2004006866A3 Antifungal therapeutic targets |
| 12/09/2004 | WO2003106474A3 Gangliosides with a modified acyl function |
| 12/09/2004 | WO2003105800A3 Film-shaped mucoadhesive administration form for administering cannabis active ingredients |
| 12/09/2004 | WO2003102588A3 Diagnostic agent, method for detecting a carcinoma, and means for the treatment thereof |
| 12/09/2004 | WO2003101422A3 Pharmaceutical preparations for oral administration, containing ion-exchange resins loaded with active ingredients and intrinsically viscous gelling agents as thickening agents |
| 12/09/2004 | WO2003097585A3 Amidoacetonitrile compounds |
| 12/09/2004 | WO2003097051A3 Use of compounds that are effective as selective opiate receptor modulators |
| 12/09/2004 | WO2003093478A9 Immunoconjugates for the treatment of tumours |
| 12/09/2004 | WO2003092468A3 Biomatrix structural containment and fixation systems and methods of use thereof |
| 12/09/2004 | WO2003080582A3 Fredericamycin derivatives |
| 12/09/2004 | WO2003072114A9 Vascular therapeutics |
| 12/09/2004 | WO2003062262A3 Modulation of heat-shock-protein-based immunotherapies |
| 12/09/2004 | WO2003057835A3 Pak5-related compositions and methods |
| 12/09/2004 | WO2003053219A3 Methods for slowing senescence and treating and preventing diseases associated with senescence |
| 12/09/2004 | WO2001076599A8 Process of making racemic bupivacaine's enantiomers, levobupivacaine's pharmaceutical compositions, levobupivacaine's pharmaceutical compositions formulated on its free base form or its pharmaceutical acceptable salts and use of levobupivacaine's pharmaceutical compositions formulated on its free base form |
| 12/09/2004 | US20040249610 Method and apparatus for system management using codebook correlation with symptom exclusion |
| 12/09/2004 | US20040249445 Medical device for delivering biologically active material |
| 12/09/2004 | US20040249175 Method for the preparation of hexahydro-furo-[2,3-b]furan-3-ol |
| 12/09/2004 | US20040249167 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 12/09/2004 | US20040249161 Biphenyl-derivatives as p38-kinase inhibitors |
| 12/09/2004 | US20040249159 Novel piperidin-2,6-dione disulphate salts and their use for the treatment of stress related affective disorders |
| 12/09/2004 | US20040249158 Amine salts of an integrin receptor antagonist |
| 12/09/2004 | US20040249153 For therapy of inflammation, rheumatoid arthritis, osteoarthritis, osteoporosis and tumors |
| 12/09/2004 | US20040249148 Hydrolase enzyme inhibitors comprising nitrogen compounds such as 2-(3,4-Dimethoxyphenyl)-7-(1-ethylpropyl)-5-methyl-4-(3,4,5-trimethoxyphenoxy)-imidazo[5,1-f][1,2,4]triazine, used for prophylaxis of neurodegenerative disorders |
| 12/09/2004 | US20040249139 Nucleotide sequences coding transmembrane cochlear-expressed gene 1(TDC1) protein for use in diagnosis, prognosis and treatment of hearing loss |
| 12/09/2004 | US20040249132 Nuclear hormone receptor ligand binding domain |
| 12/09/2004 | US20040249123 Nuclear receptor for use in identifying modulator for diagnosis, prevention and treatment of cell proliferative, blood, cardiovascular, skin, inflammatory, bone and nervous system disorders |
| 12/09/2004 | US20040248992 Method and composition for inhibiting arteriosclerosis |
| 12/09/2004 | US20040248991 comprises ubiquinones; decreasing amount of urinary 8-hydroxydeoxyquanosine in diabetic animals |
| 12/09/2004 | US20040248989 Method for the treatment or prevention of lower urinary tract symptoms |
| 12/09/2004 | US20040248988 2-Amino-1,3-propanediol compounds for the treatment of various types of pain |
| 12/09/2004 | US20040248987 N-alkyl-diphenyl-alkylene-amine derivatives; for the treatment of smooth muscle hyperactivity in urinary incontinence, gastrointestinal disorder, respiratory system disorder; promoting smooth muscle relaxation, reducing hypotension or cardiac side effects |
| 12/09/2004 | US20040248986 Treating aggressive breast cancer with tesmilifene hydrochloride; synergistic effect combine with other chemotherapeutic agent like doxorubicin, taxanes |
| 12/09/2004 | US20040248985 N-{2-[4-((R)-2-hydroxy-2-phenylethylamino)phenyl]ethyl}-(R)-2-hydroxy-2-(3-formamido-4-hydroxyphenyl)ethylamine monohydrochloride; pulmonary disease asthma or chronic obstructive pulmonary disease; administration by inhalation; salt formation, crystallization |
| 12/09/2004 | US20040248984 Use of $g(b)-adrenoceptor agonists for the treatment of neurodegenerative diseases |
| 12/09/2004 | US20040248983 Potent analgesic and antiinflammatory effects; antiinflammatory agents; treatment of pain and inflammation; N-(3-cyclohexylphenyl)-4-hydroxy-3-methoxyphenylacetamide |
| 12/09/2004 | US20040248982 Sequestering a metallic cation within a metalloprotein matrix with a electronegative picolinic acid, dipicolinic acid, 2,4 pyrazoledicarboxylic acid, lutidinic acid, isocinchomeranic acid, quinolinic acid, and lipoic acid; vertebrate diseases and disorders; preventing sunburn |
| 12/09/2004 | US20040248981 Excellent inhibitory activity against factor Xa; anticoagulants; blood coagulation disorder, thrombotic disease, cerebral infarction, myocardial infarction, or peripheral circulation disorder |
| 12/09/2004 | US20040248980 Method of treatment for irritable bowel syndrome |
| 12/09/2004 | US20040248979 Therapeutic treatment using a mixture of calcium channel blocker and a substituted aminomethyl-phenyl-cyclohexane derivative; GABA analog gabapentin, pregabalin; tramadol hydrochloride; synergistic effect; urinary frequency, urgency, and incontinence, overactive bladder, prostatitis, cystitis |
| 12/09/2004 | US20040248978 Synergistic pain treatment, side effect reduction; a mixture of pregabalin or tiagabine and 2-[4-(2-fluorobenzyloxy) benzylamino] propanamide |
| 12/09/2004 | US20040248977 Aminal feeds comprising a conjugated linoleic acid; prevent damage to mammary glands |
| 12/09/2004 | US20040248976 A DNA fragment probe is used to bind specifically to a target substance; a moisturizer is used to spot the probe to be fixed on a substrate, promote omission, stabilizing the spot shape, increase detection sensitivity of a reaction chip |
| 12/09/2004 | US20040248974 Self emulsifying drug delivery system |
| 12/09/2004 | US20040248972 A statin composition comprising a non-statin compound for reducing the inhibitory activity against HMG-CoA reductase, but have effect on PDE6 ; cardiovascular disorders, stroke, neurodegenerative disease, vision defects, leukemia, melanoma, Non-Hodgkins Lymphoma, cancer |
| 12/09/2004 | US20040248971 Treating prostate cancer; suppress the expression of prostate-specific antigen |
| 12/09/2004 | US20040248970 CBD-delta8-THC composition |
| 12/09/2004 | US20040248968 Pharmaceutical combination of angiotensin II antagonists and angiotensin I converting enzyme inhibitors |
| 12/09/2004 | US20040248967 Promoter for production of nitric oxide or nitric oxide synthase, and cosmetic or pharmaceutical composition comprising the same |
| 12/09/2004 | US20040248966 A drug contains melatonin, other melatonergic agents, melatonin agonists and melatonin antagonists, in an effective amount within the range of 0.0025 to 50 mg, and other therapeutic agent; improving the restorative quality of sleep; sustained release |
| 12/09/2004 | US20040248965 Indolin-2-one derivatives as anticarcinogenic agents for treating angiogenesis, lymphangiogenesis, filariasis |
| 12/09/2004 | US20040248964 Analgesic uses of norketamine and ketamine/norketamine prodrugs |
| 12/09/2004 | US20040248962 Ketorolac tromethamine compositions for treating or preventing ocular pain |
| 12/09/2004 | US20040248959 Adding Histamine phosphate to eye drops to improve the diagnostic results of Scrapie Disease of Sheep, Chronic Wasting Disease of Deer and Elk, Creutzfedt-Jakob disease of Humans |
| 12/09/2004 | US20040248957 Heterocyclic compounds and uses thereof |
| 12/09/2004 | US20040248956 administering G protein coupled receptor antagonists such as ethyl 1-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-5-methyl-imidazole-4-carboxylate, as neuroleptic, anxiolytic and antiinflammatory agents |
| 12/09/2004 | US20040248952 Novel bicyclic compounds and compositions |
| 12/09/2004 | US20040248950 Apo ai expression accelerating agent |
| 12/09/2004 | US20040248948 Combination therapy |
| 12/09/2004 | US20040248947 N-(3- and 4-substituted phenyl)-2-(arylamino)-benzamides; aralkylation of the 2-primary amine with a benzaldehyde or a pyrid-4-yl carbaldehyde; anticarcinogenic, antitumor agents; enzyme inhibitors of vascular endothelial growth factors |
| 12/09/2004 | US20040248946 Beverage treated with nicotine |
| 12/09/2004 | US20040248944 Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 12/09/2004 | US20040248942 Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid |
| 12/09/2004 | US20040248938 Substituted piperidines |
| 12/09/2004 | US20040248937 protein tyrosine phosphatase inhibitors such as N-[(4-{[4,6-bis(4-methoxyphenyl)pyrimidin-2-yl]amino}phenyl)sulfonyl]-N-methyl-L-phenylalanine, used for treatment of metabolic disorders related to insulin resistance or hyperglycemia |
| 12/09/2004 | US20040248936 such as (R)-1-{4-[4-(4-Phenoxy-2-propyl-phenoxy)-butoxy]-benzenesulfonyl}-azetidine-2-carboxylic acid, used as peroxisome proliferator-activated receptor agonists; hypoglycemic agents |
| 12/09/2004 | US20040248935 crystals, crystal structured, liquid crystals and/or amorphous forms of 4-[4[4-(hydroxy diphenyl methyl)-1-piperidenyl]-1-hydroxy butyl]- alpha , alpha -dimethylphenyl acetic acid, hydrochloride salts, used as antihistamines, antiallergens or bronchodilator agents |
| 12/09/2004 | US20040248933 tertiary carbocyclic amines such as 4,7-diphenyl-2-methyl-1,2,3,4-tetrahydroisoquinoline, having preferential binding norepinephrine transporter protein (NET) over the other neurotransmitter transporters; side effect reduction |
| 12/09/2004 | US20040248932 Use of aryl- and heteroaryl-substituted tetrahydroisoquinolines in the treatment of chronic and neuropathic pain, migraine headaches, and urge, stress and mixed urinary incontinence |
| 12/09/2004 | US20040248931 Poly(ADP-ribose)polymerase inhibitors; cerebral infarction; such as 3-[2-(3-hydroxypyrrolidin-1-yl)ethyl]-5-methyl-2H-isoquinolin-1-one; synthesis |
| 12/09/2004 | US20040248930 Topical composition |
| 12/09/2004 | US20040248928 Cardiovascular system protection; ischemic attack, reperfusion, cardiac surgery |
| 12/09/2004 | US20040248927 Preventive agent/remedial agent for constipation predominant ibs |
| 12/09/2004 | US20040248926 Containing tricyclic active agent having ketone and amide functionality |
| 12/09/2004 | US20040248925 Use of 4-phenyl substituted tetrahydroisoquinolines in the treatment of pain, migraine and urinary incontinence |
| 12/09/2004 | US20040248924 Compositions for treatment of common cold |
| 12/09/2004 | US20040248923 Novel 4-anilinoquinoline-3-carboxamides |
| 12/09/2004 | US20040248922 Lavendamycin analogs, quinoline-5,8-diones and methods of using them |
| 12/09/2004 | US20040248921 Reducing androgen levels; acne, prostate diseases, alopecia, hirsutism; such as 17-chloromethylene-4-aza-5-alpha-estran-3-one |
| 12/09/2004 | US20040248920 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 12/09/2004 | US20040248919 Insulin sensitizers which do not increase triglyceride levels or suppress thyroid hormone axis; such as 7-[3,5-di-tert-butyl-2-(2,2-difluoroethoxy)-phenyl]-4-fluoro-3-methyl-octa-2,4,6-trienoic acid; synthesis; retinoid X receptor (rxr) |
| 12/09/2004 | US20040248918 Anticancer agents |
| 12/09/2004 | US20040248917 Imidazo-pyridine derivatives for use in the treatment of herpes viral infection |
| 12/09/2004 | US20040248916 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 12/09/2004 | US20040248915 Method for administration of troxacitabine |
| 12/09/2004 | US20040248914 Method for the treatment of overactive bladder |
| 12/09/2004 | US20040248913 (Pyridinyl and pyrimidyl) trienoic acid derivatives as retinoid x receptor modulators |
| 12/09/2004 | US20040248912 4- (4-trans-hydroxycyclohexyl)amino-2-phenyl-7H-pyrrolo [2,3D] pyrimidine hydrogen mesylate, its polymorphic forms, and methods for making same |
| 12/09/2004 | US20040248910 Synthesis of acyclic nucleoside derivatives |
| 12/09/2004 | US20040248909 Adenosine a1 receptor antagonist for treating hypoxia-induced learning memory impairment |
| 12/09/2004 | US20040248907 reacting 4,6-dichloro-5-nitropyrimidine with acyclic carboxy amines, then cyclization of the intermediates to form cellular adhesion inhibitors |
| 12/09/2004 | US20040248906 Use of c-src inhibitors alone or in combination with st1571 for the treatment of leukaemia |
| 12/09/2004 | US20040248905 6-Substituted pyrazolo [3,4-d] pyrimidin-4-ones useful as cyclin dependent kinase inhibitors |
| 12/09/2004 | US20040248904 New piperidinylamino-thieno[2,3-d] pyrimidine compounds |
| 12/09/2004 | US20040248903 Pyrazolo-pyridine derivatives as antiherpes agents |
| 12/09/2004 | US20040248902 Central nervous system, gastrointestinal and psycological disorders; such as 3-(4-chlorobenzenesulfonyl)-2-methyl-7-piperazin-1-yl-1H-indole; synthesis |
| 12/09/2004 | US20040248901 Microemulsified with fatty acid or alcohol and surfactant; bioavailability; low cost, capsules |
| 12/09/2004 | US20040248899 Fused bicyclic-substituted amines as histamine-3 receptor ligands |
| 12/09/2004 | US20040248898 Group V and/or X secretory phospholipase A2 inhibition; suppressing degeneration of serum lipoproteins |
| 12/09/2004 | US20040248897 Substituted N-acylaniline derivatives, the preparation thereof, and their use as pharmaceutical compositions |